Search - tctmd.com

Displaying 981 - 1000 of 1109

Sort: Relevancy | Date

News Daily News

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Jason Kahn

January 08, 2012

News Daily News

SCAAR: Second-Generation DES Improve Hard Outcomes

Yael L. Maxwell

January 08, 2012

News Daily News

EVEREST II Registry Looks at MitraClip in High-Risk Patients

Jason Kahn

January 04, 2012

News Industry News

Abbott Initiates Clinical Trial To Study Drug Eluting Bioresorbable Therapy For Treatment Of Peripheral Artery Disease

December 31, 2011

News Daily News

CAS Plus Cardiac Surgery a Promising Option for Symptomatic Patients

Yael L. Maxwell

December 07, 2011

News Industry News

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

December 07, 2011

News Daily News

Some New-Generation Stents Prone to Longitudinal Distortion

November 29, 2011

News Conference News

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

L.A. McKeown

November 28, 2011

News Conference News

Two New SES Show Improvement Over First-Generation Stents

Yael L. Maxwell

November 10, 2011

News Industry News

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

November 10, 2011

News Conference News

RAPID GENE: Validation of Point-of-Care Genetic Testing

November 09, 2011

News Industry News

PARTNER QoL data hint transapical TAVI falls short of aortic-valve surgery

November 09, 2011

News Conference News

ZES and SES Equally Effective in Long Lesion Treatment

November 08, 2011

News Conference News

SPIRIT PRIME: EES Efficacy ‘Similar and Consistent’ with Xience V Technology

November 08, 2011

News Conference News

Preclinical Results Promising for Combo Stent

November 08, 2011

News Industry News

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

November 08, 2011

News Conference News

Next-Generation Devices Address Complications of TAVR

November 08, 2011

News Conference News

Low Event Rates with EES Sustained at 2 Years

November 08, 2011

News Conference News

EES Compared Favorably with SES In Two Pivotal Trials

November 08, 2011

News Industry News

Cangrelor provides effective maintenance of platelet inhibition without major bleeding for patients who require bypass surgery

November 08, 2011

Advertisement

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

SCAAR: Second-Generation DES Improve Hard Outcomes

EVEREST II Registry Looks at MitraClip in High-Risk Patients

Abbott Initiates Clinical Trial To Study Drug Eluting Bioresorbable Therapy For Treatment Of Peripheral Artery Disease

CAS Plus Cardiac Surgery a Promising Option for Symptomatic Patients

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

Some New-Generation Stents Prone to Longitudinal Distortion

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

Two New SES Show Improvement Over First-Generation Stents

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

RAPID GENE: Validation of Point-of-Care Genetic Testing

PARTNER QoL data hint transapical TAVI falls short of aortic-valve surgery

ZES and SES Equally Effective in Long Lesion Treatment

SPIRIT PRIME: EES Efficacy ‘Similar and Consistent’ with Xience V Technology

Preclinical Results Promising for Combo Stent

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

Next-Generation Devices Address Complications of TAVR

Low Event Rates with EES Sustained at 2 Years

EES Compared Favorably with SES In Two Pivotal Trials

Cangrelor provides effective maintenance of platelet inhibition without major bleeding for patients who require bypass surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content